Project
I6T-MC-AMAP
Automatically Closed · 2021 until 2024
Krieger-Grübel Claudia, Brand Stephan, Smolders Jolijn
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Automatically Closed
Start Date
2021
End Date
2024
Financing
Industry
Brief description/objective
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis LUCENT 3